These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30963821)

  • 1. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications.
    Dlamini NN; Meyer JC; Kruger D; Kurdi A; Godman B; Schellack N
    Hosp Pract (1995); 2019 Apr; 47(2):88-95. PubMed ID: 30963821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications.
    Skosana PP; Schellack N; Godman B; Kurdi A; Bennie M; Kruger D; Meyer JC
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1353-1366. PubMed ID: 33724147
    [No Abstract]   [Full Text] [Related]  

  • 3. A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications.
    Skosana PP; Schellack N; Godman B; Kurdi A; Bennie M; Kruger D; Meyer JC
    Hosp Pract (1995); 2022 Oct; 50(4):306-317. PubMed ID: 35980901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa.
    Kruger D; Dlamini NN; Meyer JC; Godman B; Kurdi A; Lennon M; Bennie M; Schellack N
    Hosp Pract (1995); 2021 Aug; 49(3):184-193. PubMed ID: 33566710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P; Goossens H
    Drugs; 2011 Apr; 71(6):745-55. PubMed ID: 21504250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national, multicentre, web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa.
    Skosana PP; Schellack N; Godman B; Kurdi A; Bennie M; Kruger D; Meyer JC
    J Glob Antimicrob Resist; 2022 Jun; 29():542-550. PubMed ID: 34915203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A web-based point prevalence survey of antimicrobial use and quality indicators at Raleigh Fitkin Memorial Hospital in the Kingdom of Eswatini and the implications.
    Gwebu PC; Meyer JC; Schellack N; Matsebula-Myeni ZC; Godman B
    Hosp Pract (1995); 2022 Aug; 50(3):214-221. PubMed ID: 35450508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial prescribing in the surgical and medical wards at a private hospital in KwaZulu-Natal, South Africa, 2019.
    Jacob VT; Mahomed S
    S Afr Med J; 2021 May; 111(6):582-586. PubMed ID: 34382571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications.
    Anand Paramadhas BD; Tiroyakgosi C; Mpinda-Joseph P; Morokotso M; Matome M; Sinkala F; Gaolebe M; Malone B; Molosiwa E; Shanmugam MG; Raseatlholo GP; Masilo J; Oyeniran Y; Marumoloa S; Maakelo OG; Katjakae I; Kgatlwane J; Godman B; Massele A
    Expert Rev Anti Infect Ther; 2019 Jul; 17(7):535-546. PubMed ID: 31257952
    [No Abstract]   [Full Text] [Related]  

  • 11. Surveillance of antimicrobial utilization in Africa: a systematic review and meta-analysis of prescription rates, indications, and quality of use from point prevalence surveys.
    Gobezie MY; Tesfaye NA; Faris AG; Hassen M
    Antimicrob Resist Infect Control; 2024 Sep; 13(1):101. PubMed ID: 39256804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial Usage and Resistance in Makkah Region Hospitals: A Regional Point Prevalence Survey of Public Hospitals.
    Haseeb A; Faidah HS; Algethamy M; Alghamdi S; Alhazmi GA; Alshomrani AO; Alqethami BR; Alotibi HS; Almutiri MZ; Almuqati KS; Albishi AA; Elrggal ME; Mahrous AJ; Khogeer AA; Saleem Z; Iqbal MS; Sheikh A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point prevalence surveys of antimicrobial use: a systematic review and the implications.
    Saleem Z; Hassali MA; Godman B; Versporten A; Hashmi FK; Saeed H; Saleem F; Salman M; Rehman IU; Khan TM
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):897-910. PubMed ID: 32394754
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey.
    Pauwels I; Versporten A; Vermeulen H; Vlieghe E; Goossens H
    Antimicrob Resist Infect Control; 2021 Sep; 10(1):138. PubMed ID: 34583775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use.
    Zarb P; Coignard B; Griskeviciene J; Muller A; Vankerckhoven V; Weist K; Goossens M; Vaerenberg S; Hopkins S; Catry B; Monnet D; Goossens H; Suetens C; ;
    Euro Surveill; 2012 Nov; 17(46):. PubMed ID: 23171822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications.
    Saleem Z; Hassali MA; Hashmi FK; Godman B; Bhutta OA
    Hosp Pract (1995); 2019 Aug; 47(3):149-154. PubMed ID: 31180791
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using periodic point-prevalence surveys to assess appropriateness of antimicrobial prescribing in Australian private hospitals.
    Cotta MO; Robertson MS; Upjohn LM; Marshall C; Liew D; Buising KL
    Intern Med J; 2014 Mar; 44(3):240-6. PubMed ID: 24372683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications.
    Fynn A; Helberg E; Godman B; Meyer JC
    Hosp Pract (1995); 2020 Mar; 48(2):92-99. PubMed ID: 32013641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point prevalence study of antimicrobial usage in acute care hospitals in the Slovak Republic.
    Štefkovičová M; Litvová S; Meluš V; Krištúfková Z; Bražinová A
    J Hosp Infect; 2016 Aug; 93(4):403-9. PubMed ID: 27156010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.